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no preoperative factors were independently associated with postoperative
mortality.
Conclusions: AGI incidence has progressively declined during the
span of our study in association with decreased open and increased endovas-
cular aortic aneurysm repairs. Aortic surgery for AGI is associated with very
highmorbidity andmortality rates, along with prolonged lengths of stay and
elevated hospital charges. The outcomes of operations for AGI are better in
younger patients and higher volume hospitals.
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Objectives:Recent single-center reports demonstrate high (up to 10%)
incidence of postoperative venous thromboembolism (VTE) after major
vascular surgery. Moreover, vascular patients rarely receive prolonged pro-
phylaxis, despite evidence that it reduces postdischarge events. The objective
of our study was to use a national, prospective, multicenter database to (1)
define the frequency of overall and postdischarge VTE after major vascular
operations and (2) assess risk factors associated with VTE development.
Methods: Patients who experienced a VTE after elective vascular
procedures (n  45,548) were identified from 2007 to 2009 National
Surgical Quality Improvement Program database. The vascular procedures
included carotid endarterectomy (CEA; n 20,785), open thoracoabdomi-
nal aneurysm (TAAA) repair (n  361), thoracic endovascular aortic repair
(TEVAR; n  732), open abdominal aortic aneurysm (AAA) repair (n 
6195), endovascular aneurysm repair (EVAR; n  7361), and infrainguinal
bypass graft (BPG; n  10,114).
Results: VTE was diagnosed in 332 patients (0.7%), consisting of
pulmonary embolism (PE) in 0.2% and deep venous thrombosis (DVT) in
0.6%. TAAA repair had the highest rate of VTE (4.2%), followed by TEVAR
(2.2%), open AAA repair (1.7%), BPG (1.0%), EVAR (0.7%), and CEA
(0.2%) (P  .0001). Forty-one percent of these VTEs were diagnosed after
discharge. The number of days (mean standard deviation) from operation
to DVT and PE were 11.12 7.76 and 11.40 8.56 days, respectively. On
multivariate analyses, type of surgical procedure, totally dependent func-
tional status, disseminated cancer, postoperative organ space infection,
postoperative cerebrovascular accident, failure to wean from ventilator48
hours and return to the operating room were significantly associated with
development of VTE (Table). In those experiencing a DVT or PE, overall
mortality increased from 1.5% to 6.2% and from 1.5% to 5.7%, respectively
(P  .05 for both).
Conclusions: Postoperative VTE is associated with type of vascular
procedure and is highest after operations in the chest and abdomen/pelvis.
About 40% of VTE events in elective vascular surgery patients were diag-
nosed after discharge. Future studies should evaluate the benefit of DVT
screening or postdischarge VTE prophylaxis in high-risk patients.
Table. Multivariate analyses of venous thromboembolism
Parameter OR 95% CI
Procedurea
TAAA 3.71 1.12-12.26
TEVAR 4.96 1.94-12.69
Open AAA 4.23 2.23-7.99
Infrainguinal bypass graft 3.33 1.67-6.63
EVAR 2.82 1.46-5.47
Totally dependent functional status 1.96 1.18-3.28
Postoperative CVA 2.58 1.14-5.81
Disseminated cancer 16.39 3.10-83.33
Organ space infection 3.25 1.10-9.61
Failure to wean 4.18 2.18-8.06
Return to operating room 2.09 1.34-3.27
AAA, Abdominal aneurysm repair; CI, confidence interval; CVA, cerebro-
vascular accident; EVAR endovascular aneurysm repair; OR, odds ratio;
TAAA, thoracoabdominal aneurysm repair; TEVAR, thoracic endovascular
aortic repair.
aReference category for procedure: carotid endarterectomy.
Effectiveness of Isolated Pectoralis Minor Tenotomy (PMT) in Se-
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Objectives: Pectoralis minor tenotomy (PMT) is a potential surgical
option for selected patients with neurogenic thoracic outlet syndrome
(NTOS. The purpose of this study was to evaluate the effectiveness of
isolated PMT as compared with supraclavicular decompression (SCD: sca-
lenectomy, neurolysis, and first rib resection) first.
Methods: Data were obtained for 200 patients undergoing opera-
tive treatment for disabling NTOS between 2008 and 2011. Patients
with physical examination findings limited to the subcoracoid space were
offered isolated PMT (n  57), whereas those with scalene triangle
findings were offered SCD first (n  143). Functional outcomes were
assessed using the Disabilities of the Arm, Shoulder and Hand (DASH)
survey instrument.
Results: There were no significant differences (P .05) between PMT
and SCD patients with respect to age (37.1 0.9 years), sex (73.0% female),
side affected (52.0% right, 14.5% bilateral), presence of depression (36.0%),
history of injury (53.5%), or the nature, duration, and magnitude of symp-
toms. Diagnostic muscle blocks were positive in 27 of 34 PMT (79.4%)
patients. Mean preoperative DASH scores were similar between PMT and
SCD groups (49.9  3.6 vs 50.8  1.6), but previous use of opiate pain
medications was higher in PMT patients (45.6% vs 20.3%, P  .0004). All
PMTs were conducted as outpatient procedures, whereas mean hospital stay
after SCD was 4.8  0.1 days. Mean DASH scores at 3 months were
significantly improved after PMT (29.6 4.2, P .0005) and SCD (39.3
2.3, P  .0001), but the extent of improvement in DASH scores was not
significantly different between groups (32.1%  9.4% vs 23.9%  4.7%).
There were also no significant differences in the proportion of patients
demonstrating functional improvement (75.0% vs 73.3%) or use of opiate
medications (35.1% vs 27.3%).
Conclusions: Isolated PMT was effective treatment for NTOS in
properly selected patients, demonstrating clinical and functional outcomes
similar to conventional SCD. These findings support an important role for
PMT in the management of NTOS.
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Objectives: This study examined associations between age, gender,
clinical factors, and outcome after EVAR.
Methods: Data on patients who underwent EVAR between 1997 and
2011 at our institution have been analyzed. SVS comorbidity scores were
used to stratify patients into good risk (score 10) or high-risk category
(score 10). End points were early and late mortality, morbidity, reinter-
ventions, ruptures, and survival. Questionnaires were mailed to update
follow-up information. The Kaplan-Meier method was used to estimate
survivals. Associations with outcomes were assessed with 2 test or Cox
proportional hazards regression.
Results: The study comprised 1008 consecutive patients (133
women, 875 men), who were a mean age of 76 years (range, 49-99
years). Technical success was 96%, including 99% for elective EVAR,
100% for symptomatic abdominal aortic aneurysms (AAA), and 95% for
ruptured AAA (RAAA; P  .001) In-hospital mortality was 1.6% (16 of
1008); elective EVAR: 1% (9 of 922), symptomatic AAA: 4.5% (2 of 44),
and RAAA: 11.9% (5 of 42; P  .001). Thirty-day elective mortality was
2.2% (8 of 369) in high-risk patients, and 0.2% (1 of 552) in good-risk
patients (P  .003). Follow-up averaged 3.4 years (range, 1 month-13.5
years). Clinical presentation (elective vs symptomatic or ruptured) was
associated with 5-year survival of 64.08% vs 56.08% or 57.42%. After
elective EVAR, 5-year survival was 72% for good-risk and 51% for
high-risk patients (P  .001); both had similar freedom from complica-
tions (75% vs 75%, P  .56), reinterventions (75% vs 78%, P  .76), or
rupture (99% vs 100%, P  .73). Age and high surgical risk were
associated with complications (P  .03) and early and all-cause late
mortality (P .001). Female gender was not associated with a significant
increase in mortality, although it was associated with complications
(Table).
Conclusions:EVAR can be performedwith a low rate of complications
and mortality, even in high-risk patients or in those with symptoms or
rupture. Urgent presentation, age over 80 years and high co-morbidity
scores are associated with complications and higher mortality. Although
female sex is associated with complications, women did not have a signifi-
cantly higher mortality than men.
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